FTHFaeth Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Faeth Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FTHEsta | $937M#8 | — | 5.4x#12 | — | — | 30.1%#5 | — | -12.2%#4 | -15.2%#3 | — | 294.5%#2 | — |
| SVRA | $1.1B#2 | — | 7.5x#13 | 4217.1x#9 | — | -23.9%#7 | -48072.8%#9 | -82.7%#13 | -93.6%#7 | — | 45.5%#5 | — |
| OBX | $1.1B#1 | — | — | — | — | -21.1%#6 | — | — | — | — | — | — |
| MLTX | $1.0B#3 | — | 2.4x#7 | — | — | -91.1%#13 | — | -53.1%#12 | -491.6%#8 | — | -77.0%#14 | — |
| AMPH | $1.0B#4 | 14.1x#1 | 2.3x#6 | 1.4x#2 | -1.7%#5 | -38.5%#10 | 19.5%#1 | 22.0%#2 | 13.2%#1 | 5#1 | -11.4%#11 | — |
| JANX | $992M#6 | — | 1.1x#1 | 99.2x#7 | -5.6%#6 | -64.7%#12 | -1576.7%#7 | -12.2%#5 | — | — | -30.7%#12 | — |
| KURA | $1.0B#5 | — | 20.9x#14 | 15.0x#4 | 25.2%#3 | -60.2%#11 | -449.9%#5 | -575.4%#14 | — | — | 36.2%#6 | — |
| PCRX | $974M#7 | 69.8x#3 | 1.5x#2 | 1.3x#1 | 3.6%#4 | 107.0%#2 | 2.6%#2 | 1.0%#3 | 1.0%#2 | — | -7.8%#10 | — |
| LXRX | $901M#9 | — | 5.2x#11 | 18.1x#5 | 60.2%#2 | 74.9%#3 | -98.2%#4 | -28.8%#8 | -26.4%#6 | — | 85.8%#3 | — |
| TBPH | $884M#11 | 16.4x#2 | 3.1x#8 | 8.2x#3 | 66.9%#1 | 287.7%#1 | -3.4%#3 | 36.6%#1 | — | — | 22.8%#7 | — |
| WVE | $882M#12 | — | 1.9x#3 | 20.6x#6 | -60.5%#8 | -110.7%#14 | -504.1%#6 | -45.1%#11 | — | — | -34.4%#13 | — |
| IMMX | $886M#10 | — | 3.9x#10 | — | — | -36.0%#9 | — | -12.8%#6 | — | — | 519.3%#1 | — |
| AVTX | $877M#13 | — | 2.0x#4 | 14861.9x#10 | -86.6%#9 | -122.8%#15 | -123601.7%#10 | -17.4%#7 | -19.3%#4 | — | 67.0%#4 | — |
| OLMA | $844M#14 | — | 2.0x#5 | — | — | -25.5%#8 | — | -37.7%#9 | — | — | 22.3%#8 | — |
| GERN | $838M#15 | — | 3.8x#9 | 3537.7x#8 | -60.2%#7 | 52.2%#4 | -28938.8%#8 | -38.2%#10 | -24.8%#5 | — | 4.0%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice